Triamcinolone Acetonide as an Adjunctive to VPDT in ARMD.
NCT00148551
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
120
Enrollment
OTHER
Sponsor class
Conditions
Age-Related Macular Degeneration
Interventions
DRUG:
Triamcinolone Acetonide
Sponsor
Canadian Retinal Trials Group
Collaborators
[object Object]
[object Object]
[object Object]